控制或逆转动脉粥样硬化是预防未来心脏病发作或中风的重要组成部分。
Controlling or reversing atherosclerosis is an important part of preventing future heart attack or stroke.
研究人员说动脉僵硬度与动脉粥样硬化或动脉变硬相联系，它是心脏病的关键因素。
Researchers say arterial stiffness is tied to atherosclerosis or hardening of the arteries, which is a key factor in heart disease.
除非出现心脏病发作及卒中，否则，即使你存在着动脉粥样硬化之类的心脏病，你也可能没有任何症状。
No symptoms if you have heart disease or atherosclerosis of a large blood vessel, unless you have a heart attack or stoke.
对某些病人，它可以使动脉粥样硬化斑块破裂形成冠状动脉血栓以致心脏病。
In some patients, this may alter atherosclerotic plaques and cause clots in coronary arteries leading to heart attacks.
鉴别和预防导致心力衰竭的公认疾病包括高血压和冠状动脉粥样硬化性心脏病是首先要预防的。
Identifying and preventing the well-recognized illnesses that lead to HF, including hypertension and coronary heart disease, should be Paramount among the approaches to prevent HF.
冠心病是冠状动脉粥样硬化性心脏病的简称。
Coronary disease is the coronal atherosclerosis heart disease's abbreviation.
动脉粥样硬化是心脏病的前兆，后者是绝经后妇女的主要死因之一。
Athlerosclerosis is the main precursor to heart disease, one of the major causes of death in post-menopausal women.
社会经济地位较低的患者有更多的动脉粥样硬化，严重的心血管疾病，心脏病发作先兆，左心功能不全，心力衰竭。
Patients in lower socioeconomic positions had more atherosclerosis, serious cardiovascular disease, prior heart attacks, left ventricular dysfunction and heart failure.
结论在动脉粥样硬化性心脏病的防治中应高度重视危险因素的控制与早期干预。
Conclusion the atherosclerosis in prevention of heart disease risk factors should pay great attention to the control and early intervention.
心包脂肪与冠状动脉心脏病事件的关联：动脉粥样硬化的多民族研究。
The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis.
近年来的研究提示，C -反应蛋白升高不仅是冠状动脉粥样硬化性心脏病的危险因子，而且是预测心血管高危事件的重要标志。
Recent studies have showed that CRP is not only a risk factor of acute coronary syndrome, but also an important marker in predicting high risk cases of cardiovascular disease.
目的：目前在发达国家冠状动脉粥样硬化性心脏病(冠心病)已成为妇女死亡的第一原因。
OBJECTIVE: at present, coronary atherosclerotic heart disease (CAHD) has become the first cause of female death in developed country.
其最常见病因是冠状动脉粥样硬化引起的冠状动脉狭窄和闭塞，因此IHD可视为冠状动脉粥样硬化性心脏病。
Its most common pathogenisis is the straightening and obstruction of the coronary arteries from atherosclerosis. Therefore, IHD is also called Atherosclerotic heart disease.
冠状动脉旁路移植术是冠状动脉粥样硬化性心脏病的常规治疗方法之一。
Coronary artery bypass grafting is one of the conventional treatment of coronary heart disease.
如充血性心例衰竭、冠状动脉粥样硬化性心脏病、肾功能衰竭、心肌梗死、脑血管意外等疾病，严重影响老年人的健康及生活质量。
Such as congestive heart failure, coronary heart disease, kidney failure, myocardial infarction and cerebrovascular accident, can serious affect the healthy and life quality of the elder.
目的：探讨“益气活血方”对冠状动脉粥样硬化性心脏病(冠心病)患者左心室功能不全的治疗效果。
Objective: To investigate the therapeutic efficacy of Yiqi Huoxue Recipe on left ventricular insufficiency with coronary atherosclerotic heart disease (CAHD).
目的：应用多普勒超声心动图测定老年冠状动脉粥样硬化性心脏病（冠心病）及高血压患者左心房的充盈、射血力、径线和功能，以探讨其改变的临床意义。
Objectives:Left atrial dimension and function, as well as its ejection force and filling in elder patients with coronary heart disease and hypertension was evaluated by Doppler echocardiography.
冠心病亦称缺血性心脏病，系指冠状动脉粥样硬化使管腔狭窄导致心肌缺氧而引起的心脏病。
Coronary disease also calls the anemic heart disease, is refers to the coronal atherosclerosis to cause the lumen to cause heart disease which narrowly the cardiac muscle oxygen deficit causes.
目的：探讨参麦注射液对老年冠状动脉粥样硬化性心脏病(冠心病)无症状心肌缺血的治疗效果。
Objective: to explore the efficiency of Shenmai Injection on treating asymptomatic myocardial ischemia in senile coronary heart disease (CHD).
主要的衡量结果为动脉粥样硬化性事件，包括致命的或非致命性缺血性心脏病，致命性的或非致命性中风及外周动脉疾病。
The main outcome measures were atherosclerotic events, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, and peripheral arterial disease.
Eurekalert发表声明说，动脉粥样硬化是动脉内脂肪沉积物导致血凝块形成，产生心绞痛，心脏病发作及卒中。
This press release issued by Eurekalert says that Atherosclerosis is the development of fatty deposits in arteries that leads to blood clot formation, angina, heart attack and stroke.
目的探讨冠状动脉粥样硬化性心脏病(CHD)患者血清血管内皮生长因子(VEGF)及一氧化氮(NO)的含量变化。
Objective to study the changes of serum levels of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in patients of coronary heart disease (CHD).
对心脏病和中风没有表现有益效果的原因，可能是否在动脉粥样硬化进程中给予维生素太晚。
The lack of benefit against heart attacks and strokes might, for instance, be the result of starting the vitamins too late in the course of atherosclerosis.
目的观察复方丹参滴丸治疗冠状动脉粥样硬化性心脏病（以下简称冠心病）心绞痛临床疗效。
Objective To observe the therapeutic effect of angina pectoris caused by coronary atherosclerotic heart disease.
然而，雌激素防止骨质疏松和动脉粥样硬化的保护作用消失后，骨折和罹患冠状动脉心脏病的风险便增加了。
However, the protective effect of estrogen against osteoporosis and atherosclerosis is lost, and risks of fracture and coronary heart disease increase.
冠状动脉粥样硬化性心脏病是临床常见病和多发病，病死率高。
Clinical coronary heart disease is common and frequently-occurring disease with high mortality rate.
冠状动脉粥样硬化性心脏病(简称冠心病)是大多数国家疾病死亡的主要原因之一。
Coronary atherosclerotic heart disease (also called coronary artery disease) is one of the main causes leading to death in most countries.
冠状动脉粥样硬化性心脏病(简称冠心病)是大多数国家疾病死亡的主要原因之一。
Coronary atherosclerotic heart disease (also called coronary artery disease) is one of the main causes leading to death in most countries.
应用推荐